The first RCT to investigate the effect of liraglutide in patients with NAFLD was the LEAN study, in which 52 patients with NASH were randomized to either 48 weeks of treatment with liraglutide (1.8 mg/day) or placebo (66)
Always consult your child's metabolic team or pediatrician regarding their specific medical risks and emergency protocols
However, one of the most common questions clinicians, pharmacists, and healthcare leaders face is: Whats the difference between a 503A vs
GLP-1 Coverage for Diabetes Most Commercial Insurance Plans and Medicare Commonly covered GLP-1 medications include: Ozempic Mounjaro Trulicity Victoza Rybelsus Some plans require step therapy , ie
The side effects are manageable for most people
Your provider must document medical necessity, often including BMI thresholds, comorbidity evidence, or failed prior weight loss interventions